Key terms
About ACST
Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ACST news
Feb 15
11:05am ET
Biotech Alert: Searches spiking for these stocks today
Feb 13
8:36am ET
Acasti Pharma (ACST) Gets a Buy from Craig-Hallum
Feb 12
8:03am ET
Acasti Pharma reports Q3 EPS (21c) vs (52c) last year
Feb 07
8:41am ET
Craig-Hallum starts ‘wrongly cast out’ Acasti Pharma with a Buy
Feb 07
7:35am ET
Acasti Pharma initiated with a Buy at Craig-Hallum
Feb 01
8:07am ET
Acasti Pharma announces poster detailing its GTX-104 STRIVE-ON Trial
Dec 29
11:00am ET
Biotech Alert: Searches spiking for these stocks today
No recent news articles are available for ACST
ACST Financials
Key terms
Ad Feedback
ACST Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ACST Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range